biologic immunomodulator agents for psoriatic arthritis (PsA) — Blue Cross Blue Shield of Illinois

Initial criteria

• Patient has diagnosis of active psoriatic arthritis
• ONE of the following: (A) inadequate response to one conventional agent (cyclosporine, leflunomide, methotrexate, sulfasalazine) after ≥3 months OR (B) intolerance or hypersensitivity to one of these conventional agents